top of page
MolecularImaging_MABmolecule_BackgroundImage.jpg

from
Precision Clinical Intelligence Ltd

MAb evolution becomes treatment revolution

What is MABVIEWER?

MABVIEWER is a revolutionary Software-as-a-Medical Device platform that combines existing molecular imaging technology with our patented algorithms to quantify patient response to a monoclonal antibody. Potential applications include:

Monoclonal antibody selection

MABVIEWER guides monoclonal antibody selection to improve patient outcomes.

MultiMAbSelection.png
PopulationSelection.png

Informing clinical trial design

MABVIEWER informs clinical trial design through identification of responder populations.

Inflammatory phenotyping

MABVIEWER delivers a step change in inflammatory phenotyping for novel target identification and validation.

MAbPhenotyping_WithTarget.png

A molecular imaging approach to precision medicine

MABVIEWER leverages existing molecular imaging technology, combined with our AI-enhanced algorithms to deliver a revolutionary approach to precision medicine.

The MABVIEWER platform

Bringing molecular imaging to the clinic

MABVIEWER overcomes the complexity usually associated with molecular imaging, allowing the full potential of this technique to be realised, delivering real value to physicians and patients.

SPECTCT_Transparent_edited_edited.png
CloudComputing_EditedNoBackground_growtika-wlQUkvDhvQw-unsplash.png

Cloud-based architecture

MABVIEWER will utilise a fully cloud-based architecture, enabling us to deliver value to physicians and patients on a global scale.

The Team

A short video introduction to MABVIEWER from Professor Tom Wilkinson, co-founder of Precision Clinical Intelligence Ltd.

An introduction to the MABVIEWER technology from Dr Michael Bennett,
co-founder of Precision Clinical Intelligence Ltd.

Contact Us

If you would like to know more about MABVIEWER, then please get in touch using the form below.

bottom of page